43063955 Label (43063955)
Losartan Potassium Tablet, Film Coated
Product Images NDC 43063-955
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 43063-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Losartan Fig1)
This appears to be a fragment of a scientific study or clinical trial involving the drugs Atenolol and Losartan Potassium. The data shows an adjusted risk reduction of 13%, with a chart showing study month intervals up to 66 months. Without additional information, it is difficult to provide a complete and accurate description.*
Figure2 (Losartan Fig2)
Figure 3 (Losartan Fig3)
Figure 3 displays primary endpoint events within different subgroups of demographics. Unfortunately, the actual data presented in the figure is not readable.*
Figure-4 (Losartan Fig4)
Chemical Structure (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
